Area of research
Pulmonary and Respiratory Medicine · Otorhinolaryngology
Research interest
Research focused on Acute promyelocytic leukemia and Cetuximab, with related work in Bevacizumab, Induction therapy, Mucositis. Notable publications include 'Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era', 'Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group...', and 'Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (NS-NSCLC): A...'.
Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non–Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508)
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303